Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.38 USD | -3.49% |
|
-7.60% | -26.60% |
06-26 | Intellia Therapeutics Names Edward Dulac CFO | MT |
06-26 | Intellia Therapeutics, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.60% | 2.16B | |
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics Names Edward Dulac CFO